RP-HPLC Method Development and Its Validation for Simultaneous Estimation of Alprazolam and Fluoxetine Hydrochloride in Pharmaceutical Dosage Form

被引:4
作者
Shukla, Shubhanjali [2 ]
Kumar, Pankaj [1 ]
Moorthy, N. S. Hari Narayana [1 ]
Shrivastava, Sushant Kumar [2 ]
Trivedi, Piyush [1 ]
Srivastava, Radhey Shyam [1 ]
机构
[1] RGPV, Sch Pharmaceut Sci, Bhopal, India
[2] BHU, Dept Pharmaceut, Varanasi, Uttar Pradesh, India
来源
EURASIAN JOURNAL OF ANALYTICAL CHEMISTRY | 2010年 / 5卷 / 03期
关键词
Alprazolam; Fluoxetine hydrochloride; RP-HPLC;
D O I
10.12973/ejac.2010.000103a
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple, specific, accurate and precise reverse phase high pressure liquid chromatographic method has been developed for the simultaneous determination of Alprazolam(Alp) and Fluoxetine Hydrochloride(Flx) in tablet dosage form by reverse phase C18 column, Phenomenex (250mm x 4.60mm), Particle Size 5 mu. The samples were analyzed by using Acetonitrile: Water in the ratio of 75: 25 (pH adjusted to 2.75 with 0.1% orthophosphoric acid) as a mobile phase at the flow rate of 1.1 ml/min in isocratic mode and detection wavelength 224 nm. Both the drugs were eluted within 5 minutes and give sharp peak with high theoretical plate count and low tailing factor. The retention time for Fluoxetine Hydrochloride and Alprazolam was found to be 2.06 and 3.14 min respectively. The validation was carried according to ICH guidelines. In linearity curve correlation coefficients for Alprazolam and Fluoxetine Hydrochloride were found to be 0.9989 and 0.9994 respectively. The percent recovery was 99.56 for Alprazolam and 99.96 for Fluoxetine Hydrochloride indicating accuracy and reliability of method. So the method can be used for estimation of combination of these drugs in tablet dosage form.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 14 条
[1]  
[Anonymous], 1993, INT C HARM GEN
[2]   Quantitation of alprazolam and α-hydroxyalplazolam in human plasma using liquid chromatography electrospray ionization MS-MS [J].
Crouch, DJ ;
Rollins, DE ;
Canfield, DV ;
Andrenyak, DM ;
Schulties, JE .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1999, 23 (06) :479-485
[3]  
Gu Jing-kai, 2002, Yaoxue Xuebao, V37, P138
[4]   Analysis of certain tranquilizers in biological fluids [J].
Hefnawy, MM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 27 (05) :661-678
[5]   Isolation, identification and determination of the major degradation product in alprazolam tablets during their stability assay [J].
Huidobro, A. L. ;
Ruperez, F. J. ;
Barbas, C. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 44 (02) :404-413
[6]   Determination of the antidepressant fluoxetine in human plasma by LC with UV detection [J].
Maya, MT ;
Domingos, CR ;
Guerreiro, MT ;
Morais, JA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 23 (06) :989-996
[7]  
Mohamed A E, 2002, J PHARM BIOMED ANAL, V30, P851
[8]   Spectrofluorimetric assay for the photodegradation products of alprazolam [J].
Nudelman, NS ;
Cabrera, CG .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (03) :887-893
[9]   Development and validation of a new HPLC analytical method for the determination of alprazolam in tablets [J].
Pérez-Lozano, P ;
García-Montoya, E ;
Orriols, A ;
Miñarro, M ;
Ticó, JR ;
Suñé-Negre, JM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 34 (05) :979-987
[10]   Determination of fluoxetine and norfluoxetine in human plasma by high-pressure liquid chromatography with fluorescence detection [J].
Raggi, MA ;
Mandrioli, R ;
Casamenti, G ;
Bugamelli, F ;
Volterra, V .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (1-2) :193-199